Company search
Investment trusts: the treatments and takeovers behind the biotech boom
From cancer to depression, new medicines will transform health outcomes.
Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Research
Please note that this research may have been paid for by the investment company. Any opinions and ratings are not endorsed by the AIC.
Kepler Trust Intelligence
13 May 2026
IBT has delivered strong outperformance as biotechnology recovers.
Related articles
Fantasy fund manager: contestants buoyed by resilient bull market
All portfolios are up as a wide range of sectors saw gains in May.
Fantasy fund manager: markets power through Iran woes
Contestants score impressive gains as big tech overcomes war worries.
Fantasy fund manager: conflict hits returns but there’s safety in space
See how our contestants’ portfolios have been hit by the conflict in Iran.
Related videos
Monthly roundup: Nick Train changes approach, IBT's impressive interims & Intel’s 25-year break even
Jo, David and Ryan discuss the latest news and results in the investment trust world.
International Biotechnology Trust plc: about our investment process
Watch this short short video from Schroders with IBT’s portfolio managers Ailsa Craig and Marek Poszepczynski, describing IBT’s investment process.
Kepler Trust Intelligence Ideas for your ISA in 2026: International Biotechnology
At lunchtimes throughout March, Kepler Trust Intelligence will host online sessions with fund managers and investors, examining a wide range of strategies and themes to meet the needs of a diversified portfolio. Every day will see a different presenter, focused on a unique option for investors which they believe deserves closer inspection...
Monthly roundup: UKW changes dividend, our portfolios head-to-head and Saba snookered?
Jo, Ryan and David discuss the latest news and results in the investment trust world.
Related industry news
Morning briefing: “Strap in” for Grainger battle as Saba follows Mike Ashley with 5% stake; Saba target Workspace cuts dividend; Molten backs Isar Aerospace; IBT and BIOG chalk up sixth bid as GSK buys Nuvalent; plus Helical, Tritax Big Box
Saba Capital has bought a 5% position in Grainger (GRI), the £1.1bn residential landlord that has been trading at around a 50% discount to net asset v...
International Biotech boosted by 250% gain from one big hitter
The £380m trust made a timely exit from one of its top stocks just before it more than halved in value.
Morning briefing: Blackstone flips Hipgnosis songs catalogues for up to $4bn; International Biotechnology scores 39% half-year return; plus Workspace, Ceiba Investments, Ecofin US Renewables, Home REIT, Augmentum Fintech
Blackstone has sold the 45,000 song Hipgnosis catalogue to Sony in a deal reported to be up to $4bn. The music rights business, renamed Recognition Mu...
Morning briefing: Ecofin US Renewables loses $800,000 a month from Whirlwind sale price; Marwyn Value posts 35% return for 2025; IBT sees fifth portfolio company bid; Pantheon Int’l bought back £10m shares in March
Ecofin US Renewables Infrastructure (RNEW), a £26m investment trust that began a managed wind-down in January 2025, saw net asset value fall 15.9% fro...
Investment company news brought to you by Citywire Financial Publishers Limited,
QuotedData by Marten & Co, Sharesify, and the armchair trader.
Data provided by Morningstar.
Company documents provided by FE fundinfo.
